Hadassah Hospital Pioneers Alpha Radiation Treatment for Recurrent Glioblastoma in Israel
How 5 Israeli newsrooms covered this story — translated into English and compared side by side.
By יעל אנקר
First reported by Mako · Aug 12, 2026
What happened
Hadassah Medical Center in Jerusalem has initiated Israel's first clinical trial using alpha radiation implanted directly into recurrent glioblastoma tumors. The innovative treatment aims to target tumors precisely while sparing healthy brain tissue. This Phase I trial assesses safety and feasibility, offering new hope for patients with limited options after standard therapies fail.
- 01Hadassah Medical Center performs Israel's first alpha radiation treatment for recurrent glioblastoma.
- 02Tiny alpha radiation sources are implanted directly into the tumor using precise neurosurgical navigation.
- 03The treatment aims to minimize damage to healthy brain tissue while targeting the tumor effectively.
- 04Glioblastoma is the most common malignant brain tumor in adults with poor prognosis after recurrence.
- 05The Phase I trial focuses on safety and feasibility before assessing treatment effectiveness.
- 06Plans exist to expand the trial to patients with brain metastases lacking other treatment options.
Summary translated & synthesized from the sources below by baba. Read each original for the full report.
Full coverage · 5 outlets
The same event, reported separately by each newsroom. Open a few to compare what each emphasizes — and what they leave out.
